Real World Evidence of PD-L1, TMB Prevalence and Efficacy of 1st Line Chemotherapy in These High or Low Population for Stage IV Urothelial Cancer
Clinical trial NCT04052113 · COMPLETED
Trial details
- NCT number
- NCT04052113
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-10-25
- Primary completion
- 2020-03-23
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.